Cytiva Cell and Gene Webinars and Podcasts

1. Elevating AAV Manufacturing WithTailored Cell Lines 9/19/2024

   Skillfully crafted cell lines can substantially enhance vector purity and yield. Watch to explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.

2. Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles 4/25/2024

   The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?

3. Process Development Optimization For GMP CAR-T Manufacturing 4/17/2024

   Explore the significance of process development optimization and key considerations including selecting an outsourcing partner for PD projects, timing, technology, and process transfer, among others.

4. Bridging The Distance To Large-Scale GMP Manufacturing Of Viral Vectors 10/26/2023

   AGC Biologics discusses its journey to the successful implementation of iCELLis™ bioreactors in their AAV and lentivirus platforms.

5. Analyzing Full And Empty AAV Capsid Ratio – In Less Than 5 Minutes 10/24/2023

   Presenters show how Capto Q run on an ÄKTA pure 25 chromatography system can be used to determine the percentage of full capsids of AAV8 and AAV9 with low sample consumption.

6. Cell Therapy Milestones, Challenges, And Forming The Future Of TILs 8/15/2023

   What enabled the evolution of TIL therapies? What does the future hold for them? And where should you concentrate your efforts to accelerate progress? Watch for answers to these questions and more.

7. Capabilities And Opportunities Of Innovative Cell Processing System In CGT 8/15/2023

   Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.

8. 3 Things To Consider For Capacity Expansion 6/2/2022

   In this panel discussion, you’ll learn from experienced colleagues who share their approaches to capacity expansion and offer tips for your success.

9. Translation Of RNA Nanomedicines From Design To Clinical 4/14/2022

   mRNA therapeutics are applicable to cancer immunotherapies, infectious diseases, and other indications that require protein replacement therapy or antibodies.

10. mRNA LNP Scale Up For GMP Vaccine Production 4/14/2022

    Explore an overview of the development and scale-up activities needed to develop high quality lipid nanoparticles and progress this saRNA vaccine to the clinic.